First Solar (FSLR.US) shares dropped nearly 2.0% on Monday after J.P. Morgan downgraded the solar panel manufacturer to “neutral” from “overweight.” J.P. Morgan’s analysts expect that recent sharp gains which occurred after the announcement of the Inflation Reduction Act, which provided additional incentives for alternative energy, will slow down in the near future.
“…we view First Solar as the biggest near/medium-term beneficiary from the Inflation Reduction Acts’ domestic manufacturing tax credits,” analyst Mark Strouse wrote in a research note. “However, with the stock up [more than] 120% over the past four months, we believe the ‘easy money’ has now been made.”
First Solar (FSLR.US) stock rose over 15.0% only in November 2022, however buyers struggle to break above key resistance at $175.00, where highs from February 2011 are located. As long as price sits below this level, a larger downward correction may occur. Nearest major support to watch is located at $125.30. On the other hand, if buyers manage to push the price above the aforementioned resistance, then the road towards highs from May 2009 at $207.00 will be left open. Source: xStation5
Daily Summary: CPI down, Markets Up
Procter & Gamble: After Earnings
"Mad Max" mode - Is Tesla in trouble?
Intel’s turnaround is showing results
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
